Alessandra Gentili

Dr. Alessandra Gentili

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2015 in JACC: Cardiovascular Interventions
Verified
Journal Article
Closed access
MBMarco Barbanti
Marco Barbanti
APAnna Sonia Petronio
Anna Sonia Petronio
FEFederica Ettori
Federica Ettori
Azeem LatibAzeem Latib
Azeem Latib
Francesco BedogniFrancesco Bedogni
Francesco Bedogni
CTCorrado Tamburino
Corrado Tamburino

1 February 2014 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Closed access
MBMichele Brignole
Michele Brignole
PDPaolo Donateo
Paolo Donateo
MTMarco Tomaino
Marco Tomaino
RMRiccardo Massa
Riccardo Massa
MIMatteo Iori
Matteo Iori
RSRichard Sutton
Richard Sutton
Background—: In the Third International Study on Syncope of Uncertain Etiology (ISSUE-3), cardiac pacing was effective in reducing recurrence of syncope in patients with presumed neurally mediated syncope (NMS) and documented asystole but syncope still recurred in 25% of them at 2 years. We have investigated the role of tilt testing (TT) in predicting recurrences. Methods and Results—: In 136 patients enrolled in the ISSUE-3, TT was positive in 76 and negative in 60. An asystolic response predicted a similar asystolic form during implantable loop recorder monitoring, with a positive predictive value of 86%. The corresponding values were 48% in patients with non–asystolic TT and 58% in patients with negative TT ( P =0.001 versus asystolic TT). Fifty-two patients (26 TT+ and 26 TT–) with asystolic neurally mediated syncope received a pacemaker. Syncope recurred in 8 TT+ and in 1 TT– patients. At 21 months, the estimated product-limit syncope recurrence rates were 55% and 5%, respectively ( P =0.004). The TT+ recurrence rate was similar to that seen in 45 untreated patients (control group), which was 64% ( P =0.75). The recurrence rate was similar between 14 patients with asystolic and 12 with non–asystolic responses during TT ( P =0.53). Conclusions—: Cardiac pacing was effective in neurally mediated syncope patients with documented asystolic episodes in whom TT was negative; conversely, there was insufficient evidence of efficacy from this data set in patients with a positive TT even when spontaneous asystole was documented. Present observations are unexpected and need to be confirmed by other studies. Clinical Trial Registration—: URL: http://www.clinicaltrials.gov . Unique identifier: NCT01463358.

1 September 2014 in JACC: Cardiovascular Interventions
Verified
Journal Article
Closed access
MBMarco Barbanti
Marco Barbanti
APAnna Sonia Petronio
Anna Sonia Petronio
DCDavide Capodanno
Davide Capodanno
FEFederica Ettori
Federica Ettori
ACAntonio Colombo
Antonio Colombo
CTCorrado Tamburino
Corrado Tamburino

6 June 2014 in EP Europace
Verified
Journal Article
Open access
PDF file
MTMarco Tomaino
Marco Tomaino
CRCristina Romeo
Cristina Romeo
EVElena Vitale
Elena Vitale
TKTeresa Kus
Teresa Kus
AMAngel Moya
Angel Moya
RSRichard Sutton
Richard Sutton
Physical counter-pressure manoeuvres (PCM) are effective in young patients with vasovagal syncope and recognizable prodromal symptoms. The aim of this study was to investigate their effectiveness in patients ≥40 years with severe neurally mediated syncope (NMS) enroled in the Third International Study on Syncope of Uncertain Etiology (ISSUE-3). In the ISSUE-3 study, 63 out of 162 patients had a diagnosis of hypotensive NMS (Types 2, 3, and 4A) documented by implantable loop recorder; of these, 40 were instructed to perform isometric leg and arm PCM therapy. Their mean age was 62 ± 13 years; 47% of patients had a history of some episodes without prodrome. A group of 45 untreated patients acted as controls. The primary endpoint was the time to first syncope recurrence. During follow-up, syncope recurred in 15 PCM patients (37%) and in 24 control patients (53%) (P = 0.14). At 21 months, the modelled syncope recurrence rates were 42% [95% confidence interval (CI): 27–61] and 64% (95% CI: 48–80), respectively (P = 0.27). In conclusion, many ISSUE-3 patients affected by hypotensive NMS have syncopal recurrence despite PCM. Older age and the absence of sufficiently long recognizable prodromal symptoms in the ISSUE-3 population might have hampered the effectiveness of PC therapy.

22 October 2022 in Antibiotics
Verified
Journal Article
Open access
PDF file
ASAndrea Di Stefano
Andrea Di Stefano
MRMilko Radicioni
Milko Radicioni
FMFrancesca Morano
Francesca Morano
AGAlessandra Gentili
Alessandra Gentili
EMElena Mallat
Elena Mallat
VFVeronica Di Fonzo
Veronica Di Fonzo
The present Phase I study investigated, for the first time, fosfomycin pharmacokinetics in humans after two 3 g doses of fosfomycin trometamol administered 27 h apart, according to the dose regimen recommended for the prophylactic indication for transrectal prostate biopsy in adult men. Plasma, urine and seminal plasma concentrations were measured after one and two consecutive doses in 24 healthy men, representative of the target population of the prophylactic indication. Prostate and seminal vesicle concentrations were estimated based on seminal plasma concentrations using a one-step regression method. The exposure to fosfomycin was very similar in rate (Cmax, tmax) after one and two doses. The AUC showed a minimal increment. On average, the apparent volume of distribution was high (>100 L), and the mean clearance had an intermediate value. The total amount and dose fraction of fosfomycin excreted in urine showed a small increment after two doses. The renal clearance was about 5 L/h. The fosfomycin concentration in the prostate and seminal vesicles showed that the antibiotic increased on average after two consecutive doses. This result confirmed the ability of fosfomycin to distribute into the prostate and into seminal vesicles after one single dose and that a two consecutive dose regimen increases the antibiotic availability inside these peripheral tissues.

12 August 2014 in Pacing and Clinical Electrophysiology
Verified
Journal Article
Closed access
PDF file
FZFranco Zoppo
Franco Zoppo
DFDomenico Facchin
Domenico Facchin
GMGiulio Molon
Giulio Molon
GZGabriele Zanotto
Gabriele Zanotto
DCDomenico Catanzariti
Domenico Catanzariti
APAlessandro Proclemer
Alessandro Proclemer